European Union · Question · QUESTION_WRITTEN
E-10-2024-002234
Commercializzazione farmaco Ryplazym in Europa
Introduced
23 October 2024
Last action
6 January 2025 · Answer
Status
answered
Sponsors
Carlo FIDANZA, Ruggero RAZZA, Chiara GEMMA, Elena DONAZZAN, Nicola PROCACCINI, Denis NESCI, Pietro FIOCCHI, Sergio BERLATO, Lara MAGONI, Francesco VENTOLA, Antonella SBERNA, Mariateresa VIVALDINI, Alessandro CIRIANI, Francesco TORSELLI, Giuseppe MILAZZO, Marco SQUARTA, Stefano CAVEDAGNA, Mario MANTOVANI, Alberico GAMBINO, Paolo INSELVINI, Daniele POLATO, Giovanni CROSETTO, Michele PICARO
Subjects
Discovery layer
Source updated
6 January 2025
Records
Official question E-10-2024-002234 from European Union at European Parliament. Dated 23 October 2024. Status: answered.
Timeline
23 October 2024
Written question
Commercializzazione farmaco Ryplazym in Europa
Source: QUESTION_WRITTEN
6 January 2025
Answer
Source: QUESTION_WRITTEN_ANSWER
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
Answer
This file cannot be previewed here. Use View or Download.
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Answer
QUESTION_WRITTEN_ANSWER · 6 January 2025
Commercializzazione farmaco Ryplazym in Europa
QUESTION_WRITTEN · IT · 31 October 2024
ViewDownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Commercializzazione farmaco Ryplazym in Europa
QUESTION_WRITTEN · IT · 31 October 2024
DownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Placing Ryplazim on the market in Europe
QUESTION_WRITTEN · EN · 31 October 2024
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Placing Ryplazim on the market in Europe
QUESTION_WRITTEN · EN · 31 October 2024
DownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Carlo FIDANZA · AUTHOR
- Ruggero RAZZA · AUTHOR
- Chiara GEMMA · AUTHOR
- · COM · ADDRESSEE
- Elena DONAZZAN · AUTHOR
- Nicola PROCACCINI · AUTHOR
- Denis NESCI · AUTHOR
- Pietro FIOCCHI · AUTHOR
- Sergio BERLATO · AUTHOR
- Lara MAGONI · AUTHOR
- Francesco VENTOLA · AUTHOR
- Antonella SBERNA · AUTHOR
- Mariateresa VIVALDINI · AUTHOR
- Alessandro CIRIANI · AUTHOR
- Francesco TORSELLI · AUTHOR
- Giuseppe MILAZZO · AUTHOR
- Marco SQUARTA · AUTHOR
- Stefano CAVEDAGNA · AUTHOR
- Mario MANTOVANI · AUTHOR
- Alberico GAMBINO · AUTHOR
- Paolo INSELVINI · AUTHOR
- Daniele POLATO · AUTHOR
- Giovanni CROSETTO · AUTHOR
- Michele PICARO · AUTHOR
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.europarl.europa.eu/doceo/document/E-10-2024-002234_EN.html
- Open data entity: https://data.europarl.europa.eu/api/v2/parliamentary-questions/E-10-2024-002234
- eu · E-10-2024-002234 · source updated 6 January 2025